MicroRNA-124 expression machinery (miR-124 expression machinery)

The **miR-124 expression machinery** encompasses the cellular processes and molecular machines responsible for the transcription, processing, export, and maturation of microRNA-124, a highly conserved and brain-enriched microRNA important for regulating gene expression in neuronal cells[3][5][6]. Its biogenesis begins with transcription of miR-124 genes by RNA polymerase II, followed by processing of primary miR-124 transcripts into precursor miRNA by DROSHA and DGCR8[3][5]. The precursor is exported from the nucleus by exportin 5, then is cleaved by DICER and TRBP in the cytoplasm to generate mature miR-124, which loads into the RNA-induced silencing complex (RISC) with Argonaute proteins to regulate target mRNAs via degradation or translational inhibition[3][5]. miR-124 exerts critical control over neural stem cell differentiation, neuronal maturation, mitochondrial function, cell cycle, and synaptic plasticity[1][2][4][5][7]. Dysregulation of miR-124 machinery is linked to cancer, neurodegenerative and neurodevelopmental disorders, and inflammation through effects on neuronal and immune cell gene networks[9][5][7]. Direct pharmacological targeting of the entire "machinery" is not established; current research focuses on modulating miR-124 levels and/or its biogenesis components for therapeutic purposes[3][5][7][9].

Other names

miR-124 biogenesis machinerymiR-124 regulatory apparatusmiR-124 processing pathwayComponents of miR-124 production (e.g., DROSHA, DICER, exportin 5, TRBP, ELAVL3, AGO complex)

Drugs modulating this pathway act by: - Increasing or decreasing miR-124 levels via mimics or inhibitors - Affecting transcription (using gene editing approaches) - Targeting biogenesis enzymes (e.g. DICER, DROSHA inhibitors/modulators)